Medical Students Articles

Med Student

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chen Y et al. – Subclinical reactivation of JC virus occurs frequently in natalizumab–treated patients with multiple sclerosis. Viral shedding is associated with a transient drop in the JC virus–specific cellular immune response.

Related Articles

Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/09/09    Relevance Score: 87%

Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/26/09    Relevance Score: 84%

Targeted Therapies in Inflammatory Bowel Disease
Digestive Diseases, 11/11/09    Relevance Score: 82%

Treatment of multiple sclerosis: role of natalizumab
Neurological Sciences, 11/18/09    Relevance Score: 80%

Multiple sclerosis. Part 2: Ophthalmic issues in MS therapy
Current Opinion in Ophthalmology, 10/29/09    Relevance Score: 80%

Today in Infectious Disease...keeping you current

Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy
Clinical Infectious Diseases, 12/07/09

The Impact of The President’s Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and Why It Remains Essential
Clinical Infectious Diseases, 12/07/09

Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address